tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Eli Lilly and Co

LLY
Add to Watchlist
1185.665USD
+22.655+1.95%
Close 07-23 16:00（ET）Quotes delayed by 15 min
1.12TMarket Cap
42.04P/E TTM

Eli Lilly and Co

1185.665
+22.655+1.95%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

LLY Financials

See Eli Lilly and Co's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Eli Lilly and Co Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/6.02
Revenue / Forecast
--/20.66B
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
65.18B
44.70%
EPS(YoY)
23.00
95.62%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
169.30%8.27
51.18%7.41
477.97%6.22
91.42%6.30
23.31%3.07
101.48%4.90
1788.21%1.08
68.05%3.29
66.81%2.49
13.18%2.43
---0.06
--1.96
--1.49
--2.15
--4.78
----
----
----
----
----
Revenue
55.55%19.80B
42.56%19.29B
53.87%17.60B
37.64%15.56B
45.17%12.73B
44.68%13.53B
20.43%11.44B
35.98%11.30B
25.98%8.77B
28.10%9.35B
36.84%9.50B
28.11%8.31B
-10.88%6.96B
-8.73%7.30B
2.49%6.94B
-3.74%6.49B
14.76%7.81B
7.53%8.00B
17.98%6.77B
22.56%6.74B
Net Profit
168.04%7.40B
50.52%6.64B
475.34%5.58B
90.78%5.66B
23.02%2.76B
101.39%4.41B
1790.42%970.30M
68.27%2.97B
66.77%2.24B
13.01%2.19B
-103.95%-57.40M
85.11%1.76B
-29.32%1.34B
12.26%1.94B
30.77%1.45B
-31.48%952.50M
40.40%1.90B
-18.46%1.73B
-8.13%1.11B
-1.54%1.39B
Net Margin
72.32%37.36%
5.59%34.41%
273.92%31.72%
38.60%36.38%
-15.26%21.68%
39.19%32.59%
1503.66%8.48%
23.75%26.25%
32.38%25.58%
-11.78%23.41%
---0.60%
--21.21%
--19.32%
--26.54%
--20.28%
----
----
----
----
----
Gross Margin
-0.72%81.93%
0.35%82.52%
2.33%82.91%
4.29%84.27%
1.99%82.53%
1.67%82.24%
0.75%81.02%
3.25%80.80%
5.59%80.91%
2.65%80.88%
--80.42%
--78.26%
--76.63%
--78.80%
--76.07%
----
----
----
----
----
Debt to assets ratio
-13.66%37.20%
-11.59%37.79%
-10.15%36.98%
-1.64%39.54%
5.11%43.09%
8.45%42.74%
18.20%41.16%
17.08%40.20%
15.40%40.99%
20.11%39.41%
--34.82%
--34.33%
--35.52%
--32.81%
--33.48%
----
----
----
----
----
Income Statement
Revenue
55.55%19.80B
42.56%19.29B
53.87%17.60B
37.64%15.56B
45.17%12.73B
44.68%13.53B
20.43%11.44B
35.98%11.30B
25.98%8.77B
28.10%9.35B
36.84%9.50B
28.11%8.31B
-10.88%6.96B
-8.73%7.30B
2.49%6.94B
-3.74%6.49B
14.76%7.81B
7.53%8.00B
17.98%6.77B
22.56%6.74B
Operating profit
84.43%9.78B
58.17%8.99B
89.11%8.39B
63.12%7.02B
102.40%5.30B
84.59%5.68B
29.45%4.43B
93.63%4.30B
63.82%2.62B
45.56%3.08B
76.08%3.43B
34.67%2.22B
-37.78%1.60B
-11.83%2.11B
-5.34%1.95B
15.55%1.65B
54.24%2.57B
3.01%2.40B
48.96%2.06B
-0.71%1.43B
Net Profit
168.04%7.40B
50.52%6.64B
475.34%5.58B
90.78%5.66B
23.02%2.76B
101.39%4.41B
1790.42%970.30M
68.27%2.97B
66.77%2.24B
13.01%2.19B
-103.95%-57.40M
85.11%1.76B
-29.32%1.34B
12.26%1.94B
30.77%1.45B
-31.48%952.50M
40.40%1.90B
-18.46%1.73B
-8.13%1.11B
-1.54%1.39B
Balance Sheet
Current assets
32.90%54.84B
69.91%55.63B
97.58%62.07B
65.06%49.85B
63.81%41.26B
27.26%32.74B
36.55%31.42B
41.59%30.20B
21.03%25.19B
42.65%25.73B
30.43%23.01B
24.64%21.33B
22.67%20.81B
-2.26%18.03B
-0.95%17.64B
-1.04%17.12B
2.17%16.96B
5.67%18.45B
9.66%17.81B
18.61%17.30B
Total current liabilities
21.84%36.63B
24.14%35.23B
62.68%40.14B
43.87%39.02B
61.67%30.07B
3.97%28.38B
12.16%24.67B
43.38%27.12B
16.17%18.60B
59.25%27.29B
40.54%22.00B
21.09%18.91B
19.60%16.01B
13.85%17.14B
14.40%15.65B
3.49%15.62B
14.27%13.39B
20.60%15.05B
14.24%13.68B
25.90%15.09B
Total assets
30.41%116.58B
42.89%112.48B
52.02%114.94B
40.41%100.92B
39.79%89.39B
22.98%78.71B
30.55%75.61B
31.12%71.87B
20.28%63.94B
29.33%64.01B
22.03%57.92B
16.47%54.81B
13.31%53.16B
1.40%49.49B
-1.51%47.46B
-1.56%47.06B
0.17%46.92B
4.66%48.81B
9.65%48.19B
13.92%47.81B
Total liabilities
16.09%85.38B
33.36%85.94B
48.62%91.08B
41.78%82.57B
44.07%73.54B
21.26%64.44B
31.49%61.29B
33.38%58.24B
21.92%51.05B
37.27%53.14B
24.97%46.61B
13.70%43.66B
11.78%41.87B
-2.36%38.71B
-7.30%37.30B
-6.66%38.40B
-5.74%37.46B
-2.83%39.65B
3.29%40.23B
9.15%41.15B
Total equity
96.87%31.20B
85.93%26.54B
66.55%23.85B
34.57%18.35B
22.87%15.85B
31.37%14.27B
26.65%14.32B
22.30%13.64B
14.19%12.90B
0.82%10.86B
11.23%11.31B
28.76%11.15B
19.37%11.29B
17.70%10.78B
27.81%10.17B
29.95%8.66B
33.28%9.46B
57.16%9.15B
59.21%7.95B
55.98%6.66B
Cash Flow Statement
Net operating income
220.18%5.33B
30.35%3.22B
138.04%8.84B
110.54%3.09B
42.85%1.67B
893.14%2.47B
69.53%3.71B
132.03%1.47B
-32.62%1.17B
-118.76%-311.90M
-1.23%2.19B
-47.65%631.90M
-30.75%1.73B
-22.90%1.66B
35.89%2.22B
-32.01%1.21B
47.24%2.50B
18.80%2.16B
-9.70%1.63B
-28.85%1.78B
Net investment
-16.82%-3.92B
-45.91%-2.80B
25.52%-2.98B
16.55%-1.83B
-184.67%-3.35B
34.33%-1.92B
-30.00%-4.00B
-378.92%-2.20B
-70.96%-1.18B
-209.94%-2.92B
-222.46%-3.08B
46.01%-459.10M
32.06%-688.80M
-148.94%-943.50M
-54.96%-955.30M
-75.94%-850.30M
21.01%-1.01B
43.78%-379.00M
-96.65%-616.50M
-129.71%-483.30M
Net financing
-351.50%-3.47B
-1177.20%-2.88B
151.30%531.00M
-180.03%-1.24B
543.21%1.38B
-106.36%-225.40M
-63.06%211.30M
250.52%1.56B
-175.50%-311.30M
410.56%3.54B
145.28%572.00M
-735.41%-1.03B
114.32%412.30M
25.23%-1.14B
-172.73%-1.26B
88.58%-123.70M
-171.95%-2.88B
-18.20%-1.53B
-65.96%-463.20M
35.26%-1.08B

FAQs

What is the total revenue of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its total revenue reached 65.18B, with a year-on-year change of 45.04B.

What are the current assets of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its current assets were 55.63B, with a year-on-year change of 69.91.

What are the total assets of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its total assets of Eli Lilly and Co were 112.48B, with a year-on-year change of 42.89.

What are the total liabilities of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its total liabilities of Eli Lilly and Co were 85.94B, with a year-on-year change of 33.36.

What is the total equity of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its total equity of Eli Lilly and Co was 26.54B, with a year-on-year change of 85.93.

What is the net operating income of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its net operating income of Eli Lilly and Co was 29.70B, with a year-on-year change of 74.27.

What is the net investment of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its net investment of Eli Lilly and Co was -10.97B, with a year-on-year change of -17.96.

What is the net financing of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its net financing of Eli Lilly and Co was -2.21B, with a year-on-year change of -279.90.

What is the Earnings Per Share (EPS) of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its Earnings Per Share (EPS) was 23.00, with a year-on-year change of 95.62.

What is the net income of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its net income was 20.64B, with a year-on-year change of 94.90.

What is the net margin of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its net profit margin was 31.67, with a year-on-year change of 34.69.

What is the gross margin of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its gross margin was 83.04, with a year-on-year change of 2.13.

What is the debt-to-asset ratio of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its debt-to-asset ratio was 37.79, with a year-on-year change of -11.59.

What is the Return on Equity (ROE) of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its Return on Equity (ROE) was 101.36, with a year-on-year change of 19.47.

What is the Return on Assets (ROA) of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its Return on Assets (ROA) was 21.59, with a year-on-year change of 45.49.

What is the operating profit of Eli Lilly and Co?

According to Eli Lilly and Co's FY2025 earnings report, its operating profit was 29.70B, with a year-on-year change of 74.27.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy